Internal Medicine · Carson City, NV
NPI
1942210349
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
550 W Washington St, Suite 1
Carson City, NV, 89703
Phone (775) 883-3953
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,327 services
Medicare patients, 2024
266
Average age 76
Drug cost, 2024
$1.0M
4,494 prescriptions
Company payments, 2025
$1,808
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by B A Bottenberg was code 99213 (office e&m - established), 439 times for 180 patients. In total B A Bottenberg billed 1,327 services in 26 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 439 | 180 | $61.22 | $27K |
| 99214 Office E&M - Established | Office | 360 | 170 | $87.65 | $32K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 172 | 172 | $126.55 | $22K |
| 90662 Vaccine Product | Office | 79 | 78 | $78.32 | $6,187 |
| G0008 Administration of influenza virus vaccine | Office | 79 | 78 | $31.72 | $2,506 |
| 99211 Office E&M - Established | Office | 46 | 46 | $16.40 | $754 |
| 20552 Musculoskeletal | Office | 26 | 25 | $37.71 | $981 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 21 | 18 | $160.80 | $3,377 |
| 93000 Electrocardiogram | Office | 16 | 15 | $10.43 | $167 |
| 99204 Office E&M - New | Office | 13 | 13 | $109.87 | $1,428 |
By year: 2022 $67K for 978 services; 2023 $94K for 1,251 services; 2024 $99K for 1,327 services.
Medicare prescription drug claims, 2024
In 2024, the drug B A Bottenberg prescribed most often to Medicare patients was Atorvastatin Calcium, with 404 prescriptions and refills. In total B A Bottenberg wrote 4,494 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 404 | 1,197 | 119 | $4,230 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 151 | 443 | 46 | $2,481 |
| Levothyroxine Sodium Generic | 148 | 427 | 44 | $1,393 |
| Bisoprolol-Hydrochlorothiazide Bisoprolol/Hydrochlorothiazide | 138 | 373 | 42 | $3,866 |
| Rosuvastatin Calcium Generic | 134 | 395 | 38 | $1,783 |
| Losartan Potassium Generic | 125 | 361 | 40 | $1,401 |
| Amlodipine Besylate Generic | 121 | 327 | 36 | $853 |
| Ezetimibe Generic | 120 | 347 | 34 | $3,253 |
| Mounjaro Tirzepatide | 108 | 127 | 19 | $131K |
| Ezetimibe-Simvastatin Ezetimibe/Simvastatin | 91 | 265 | 29 | $5,782 |
| Alprazolam Generic | 79 | 88 | 14 | $470 |
| Tamsulosin Hcl Generic | 76 | 219 | 26 | $1,611 |
| Metformin Hcl Generic | 75 | 205 | 21 | $848 |
| Sertraline Hcl Generic | 73 | 181 | 26 | $839 |
| Ozempic Semaglutide | 68 | 130 | 18 | $115K |
Brand drugs: 832 claims; generic drugs: 3,644 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid B A Bottenberg $1,808 ($1,808 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $271.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $271 |
| Amgen Inc. AMGN | 7 | $205 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $199 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $188 |
| Mayne Pharma Commercial LLC | 8 | $167 |
| Aimmune Therapeutics, Inc. | 7 | $164 |
| Novo Nordisk Inc NVO | 2 | $134 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $118 |
| Pfizer Inc. PFE | 2 | $116 |
| Si-Bone, Inc. SIBN | 1 | $71.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.